The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis

New England Journal of Medicine

Volumn 330, Issue 17, 1994, Pages 1179-1184

  Weis, Stephen E ^a,b   Slocum, Philip C ^a   Blais, Francis X ^a   King, Barbara ^b   Nunn, Mary ^a   Matney, G Burgis ^b   Gomez, Enriqueta ^c   Foresman, Brian H ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b Tarrant County Public Health Department   (United States)

^c JOHN PETER SMITH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN;

ADOLESCENT; ADULT; ARTICLE; BACTERIUM CULTURE; DISEASE ASSOCIATION; DRUG ABUSE; DRUG SENSITIVITY; FEMALE; HOMELESSNESS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; RECURRENCE RISK; RELAPSE; RISK FACTOR; TREATMENT PLANNING; TUBERCULOSIS;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RECURRENCE; TEXAS; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 0028274105     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199404283301702     Document Type: Article

References (34)

1. Rieder HL, Cauthen GM, Kelly GD, Bloch AB, Snider DE Jr Tuberculosis in the United States. JAMA 1989; 262: 385-389
2. Brudney K, Dobkin J Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis 1991; 144: 745-749
3. Frieden TR, Sterling T, Pablos-Mendez A, Kilburn JO, Cauthen GM, Dooley SW The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993; 328: 521-526
4. Combs DL, O'Brien RJ, Geiter LJ USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. Ann Intern Med 1990; 112: 397-406
5. Kim SJ, Hong YP Drug resistance of Mycobacterium tuberculosis in Korea. Tuber Lung Dis 1992; 73: 219-224
6. Comstock GW, Cauthen GM. Epidemiology of tuberculosis. In: Reichman LB, Hershfield ES, eds. Tuberculosis: a comprehensive international approach. Vol. 66 of Lung biology in health and disease. New York: Marcel Dekker, 1993:23-48.
7. O'Brien RJ. The treatment of tuberculosis. In: Reichman LB, Hershfield ES, eds. Tuberculosis: a comprehensive international approach. Vol. 66 of Lung biology in health and disease. New York: Marcel Dekker, 1993:207-40.
8. Davis MS Predicting non-compliant behavior. J Health Soc Behav 1967; 8: 265-271
9. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL How often is medication taken as prescribed? A novel assessment technique. JAMA 1989; 261: 3273-3277 [Erratum, JAMA 1989;262:1472.]
10. Outpatient P.A.S. therapy, W.M., Dixon, P., Stradling, I.D.P., Wootton, Lancet, (1957), 2, 871-872
11. Mahmoudi A, Iseman MD Pitfalls in the care of patients with tuberculosis: common errors and their association with the acquisition of drug resistance. JAMA 1993; 270: 65-68
12. Cohn DL, Catlin BJ, Peterson KL, Judson FN, Sbarbaro JA A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis: a twice-weekly, directly observed, and cost-effective regimen. Ann Intern Med 1990; 112: 407-415
13. Dutt AK, Moers D, Stead WW Short-course chemotherapy for tuberculosis with mainly twice-weekly isoniazid and rifampin: community physicians' seven-year experience with mainly outpatients. Am J Med 1984; 77: 233-242
14. A controlled comparison of a twice-weekly and three once-weekly regimens in the initial treatment of pulmonary tuberculosis, Bull World Health Organ, (1970), 43, 143-206
15. Hong Kong Chest Service/British Medical Research Council. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide: results at 30 months. Am Rev Respir Dis 1991; 143: 700-706
16. Outbreak of multidrug-resistant tuberculosis — Texas, California, and Pennsylvania, MMWR Morb Mortal Wkly Rep, (1990), 39, 369-372
17. Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system — New York, 1991, MMWR Morb Mortal Wkly Rep, (1992), 41, 507-509
18. Fischl MA, Uttamchandani RB, Daikos GL, An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection. Ann Intern Med 1992; 117: 177-183
19. Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CR Jr Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med 1993; 328: 527-532
20. Kopanoff DE, Snider DE Jr, Johnson M Recurrent tuberculosis: why do patients develop disease again? A United States Public Health Service cooperative survey. Am J Public Health 1988; 78: 30-33
21. Addington WW Patient compliance: the most serious remaining problem in the control of tuberculosis in the United States. Chest 1979; 76: Suppl: 741-743
22. Simpson JM Simple tests for detection of urinary PAS. Tubercle 1956; 37: 333-340
23. Sbarbaro JA Public health aspects of tuberculosis: supervision of therapy. Clin Chest Med 1980; 1: 253-263
24. Blackwell B Drug therapy: patient compliance. N Engl J Med 1973; 289: 249-252
25. Sumartojo E When tuberculosis treatment fails: a social behavioral account of patient adherence. Am Rev Respir Dis 1993; 147: 1311-1320
26. Fox W The problem of self-administration of drugs; with particular reference to pulmonary tuberculosis. Tubercle 1958; 39: 269-274
27. Haynes RB, Taylor DW, Sackett DL, eds. Compliance in health care. Baltimore: Johns Hopkins University Press, 1979:35-40.
28. Sbarbaro JA The nature of man and physician. Am Rev Respir Dis 1981; 123: 147-147
29. Controlled trial of 6- and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong, Tubercle, (1975), 56, 81-96
30. McDonald RJ, Memon AM, Reichman LB Successful supervised ambulatory management of tuberculosis treatment failures. Ann Intern Med 1982; 96: 297-302
31. Iseman MD, Cohn DL, Sbarbaro JA Directly observed treatment of tuberculosis: we can't afford not to try it. N Engl J Med 1993; 328: 576-578
32. Annas GJ Control of tuberculosis — the law and the public's health. N Engl J Med 1993; 328: 585-588
33. Prager K. A PC approach to TB control. Wall Street Journal. December 30, 1992:A6.
34. Fox W Compliance of patients and physicians: experience and lessons from tuberculosis-II. BMJ 1983; 287: 101-105